联合费德拉提尼布和维尼托克拉克斯对具有高FLT3表达的人类B-ALL具有活性
Sean P Rinella1, Haley C Bell1, Nicholas J Hess1
1Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI.
bioRxiv : the preprint server for biology
|June 19, 2023
概括
费德拉提尼布和威尼托克拉克斯的联合治疗对治疗复发性/耐药B细胞急性淋巴细胞白血病 (B-ALL) 有希望. 这种双药方法在临床前模型中表现出卓越的疗效,特别是在表达Flt3.3的B-ALL中.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 复发性/耐药性B细胞急性淋巴细胞白血病 (B-ALL) 存在重大治疗挑战,特别是在对传统疗法的反应不佳的患者中.
- 现有的治疗方法在某些B-ALL亚型中通常有效性有限,需要新的治疗策略.
结论:
- 费德拉提尼布和venetoclax的联合治疗是对人类B-ALL的有效策略,特别是在表达Flt3的亚型中.
- 这种组合方法为治疗复发性/耐药性B-ALL提供了一个有希望的新途径.
- 需要进一步的临床研究来探索这种药物组合的治疗潜力.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K